DSpace at RU >

Browsing by Author Horiot, J.C.

Full Text	Issue Date	Title	Author(s)
	2009	Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.	Jones, H.A.; Antonini, N.; Hart, A.A.; Peterse, J.L.; Horiot, J.C., et al
	2009	The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment.	Uwini, S. Al; Antonini, N.; Poortmans, P.M.; Boersma, L.; Hurkmans, C., et al
	2008	The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.	Poortmans, P.M.; Collette, L.; Bartelink, H.; Struikmans, H.; Bogaert, W.F. van den, et al
	2008	Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.	Collette, S.; Collette, L.; Budiharto, T.; Horiot, J.C.; Poortmans, P.M., et al
	2007	Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.	Antonini, N.; Jones, H.; Horiot, J.C.; Poortmans, P.; Struikmans, H., et al
	2007	Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.	Bartelink, H.; Horiot, J.C.; Poortmans, P.M.; Struikmans, H.; Bogaert, W. van den, et al
	2004	The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.	Poortmans, P.; Bartelink, H.; Horiot, J.C.; Struikmans, H.; Bogaert, W. van den, et al
	1996	A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.	Karim, A.B.M.F.; Maat, B.; Hatlevoll, R.; Menten, J.; Rutten, E.H.J.M., et al